Advertisement
Advertisement

ProQR Therapeutics sees cash runway into mid-2027

At June 30, 2025, ProQR held cash and cash equivalents of approximately EUR 119.8 million, compared to EUR 149.4 million at December 31, 2024.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1